Long Path Partners LP
In its 13F for Q4 2025 (holdings as of December 31, 2025, filed February 17, 2026), Long Path Partners LP reported 7 stock positions worth $292.4 million. Its top holding was Ncino (NCNO) at 32.1% of the portfolio, followed by Alkami Technology (ALKT, 24.8%) and Corpay (CPAY, 13.9%). Compared with Q3 2025, it opened 1 new position, sold out of 1, added to 3 and reduced 3. The biggest buy was a new position in Mesa Laboratories (MLAB) and the biggest sale Docebo (DCBO, shares −4%).
- Most Recent 13F
- Q2 2026
- Location
- Stamford, CT
- CIK
- 0001905112
- Portfolio Value
- $292.4M (Q4 2025)
- SEC Filing
- 0000919574-26-000992 ↗ filed Feb 17, 2026
Holdings Value
Holdings 7 stocks · $292.4M
| NCNO Ncino Inc. | 32.15% | 3,666,222 | $94.0M | Add +8.9% |
| ALKT Alkami Technology Inc. | 24.78% | 3,141,115 | $72.5M | Add +22.3% |
| CPAY Corpay Inc. | 13.91% | 135,144 | $40.7M | Reduce -0.6% |
| IIIV I3 Verticals Inc. Class A | 9.42% | 1,093,418 | $27.5M | Add +5.2% |
| DCBO Docebo Inc. | 7.40% | 975,088 | $21.6M | Reduce -4.0% |
| PCOR Procore Technologies Inc. | 6.24% | 250,832 | $18.2M | Reduce -10.1% |
| MLAB Mesa Laboratories Inc. | 6.10% | 227,223 | $17.8M | New |
Portfolio Sells Q3 2025 → Q4 2025
Portfolio Buys Q3 2025 → Q4 2025
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 10 | $234.6M | NCNO, MLAB, ALKT, CPAY, TYL |
| Q1 2026 | 9 | $220.1M | NCNO, MLAB, ALKT, CPAY, TYL |
| Q4 2025 | 7 | $292.4M | NCNO, ALKT, CPAY, IIIV, DCBO |
| Q3 2025 | 7 | $276.6M | NCNO, ALKT, CPAY, IIIV, DCBO |
| Q2 2025 | 6 | $294.6M | NCNO, CPAY, DCBO, ALKT, IIIV |
| Q1 2025 | 10 | $258.7M | NCNO, PCOR, CPAY, DCBO, IIIV |
| Q4 2024 | 11 | $308.6M | NCNO, PCOR, DCBO, CRM, CPAY |
| Q3 2024 | 10 | $308.3M | NCNO, CPAY, DCBO, CRM, LBRDK |
| Q2 2024 | 10 | $252.3M | NCNO, CPAY, DCBO, PCOR, ALKT |
| Q1 2024 | 9 | $190.0M | CPAY, NCNO, ALKT, CRM, DCBO |